Citizens Financial Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.89M | Buy |
80,552
+28,098
| +54% | +$1.64M | 0.07% | 185 |
|
|
2025
Q4 | $2.83M | Buy |
52,454
+3,171
| +6% | +$153K | 0.04% | 235 |
|
|
2025
Q3 | $2.22M | Buy |
49,283
+5,070
| +11% | +$237K | 0.03% | 269 |
|
|
2025
Q2 | $2.05M | Buy |
44,213
+8,876
| +25% | +$436K | 0.03% | 255 |
|
|
2025
Q1 | $2.16M | Buy |
35,337
+5,395
| +18% | +$314K | 0.04% | 227 |
|
|
2024
Q4 | $1.69M | Sell |
29,942
-3,053
| -9% | -$171K | 0.03% | 238 |
|
|
2024
Q3 | $1.71M | Sell |
32,995
-2,208
| -6% | -$104K | 0.03% | 233 |
|
|
2024
Q2 | $1.46M | Buy |
35,203
+8,070
| +30% | +$361K | 0.03% | 237 |
|
|
2024
Q1 | $1.47M | Sell |
27,133
-560
| -2% | -$28.5K | 0.05% | 177 |
|
|
2023
Q4 | $1.42M | Buy |
27,693
+1,646
| +6% | +$86.4K | 0.05% | 187 |
|
|
2023
Q3 | $1.51M | Sell |
26,047
-3,378
| -11% | -$207K | 0.06% | 154 |
|
|
2023
Q2 | $1.88M | Buy |
29,425
+670
| +2% | +$44.9K | 0.07% | 165 |
|
|
2023
Q1 | $1.99M | Sell |
28,755
-50
| -0.2% | -$3.53K | 0.07% | 167 |
|
|
2022
Q4 | $2.07M | Sell |
28,805
-2,174
| -7% | -$164K | 0.08% | 145 |
|
|
2022
Q3 | $2.2M | Buy |
30,979
+309
| +1% | +$22.4K | 0.1% | 136 |
|
|
2022
Q2 | $2.36M | Buy |
30,670
+3,147
| +11% | +$240K | 0.1% | 133 |
|
|
2022
Q1 | $2.01M | Sell |
27,523
-925
| -3% | -$62.1K | 0.07% | 151 |
|
|
2021
Q4 | $1.75M | Sell |
28,448
-2,778
| -9% | -$163K | 0.06% | 164 |
|
|
2021
Q3 | $1.85M | Sell |
31,226
-1,347
| -4% | -$88.7K | 0.07% | 160 |
|
|
2021
Q2 | $2.18M | Buy |
32,573
+1,084
| +3% | +$70.7K | 0.09% | 130 |
|
|
2021
Q1 | $1.99M | Buy |
31,489
+532
| +2% | +$33.1K | 0.1% | 122 |
|
|
2020
Q4 | $1.92M | Sell |
30,957
-1,261
| -4% | -$77.5K | 0.11% | 122 |
|
|
2020
Q3 | $1.93M | Buy |
32,218
+1,090
| +4% | +$65.6K | 0.12% | 114 |
|
|
2020
Q2 | $1.83M | Sell |
31,128
-1,907
| -6% | -$114K | 0.13% | 116 |
|
|
2020
Q1 | $1.84M | Sell |
33,035
-1,437
| -4% | -$87.8K | 0.15% | 108 |
|
|
2019
Q4 | $2.21M | Buy |
34,472
+5,131
| +17% | +$294K | 0.15% | 110 |
|
|
2019
Q3 | $1.49M | Sell |
29,341
-494
| -2% | -$23.2K | 0.11% | 116 |
|
|
2019
Q2 | $1.35M | Sell |
29,835
-2,106
| -7% | -$98.1K | 0.1% | 116 |
|
|
2019
Q1 | $1.52M | Sell |
31,941
-3,205
| -9% | -$160K | 0.11% | 118 |
|
|
2018
Q4 | $1.83M | Sell |
35,146
-2,335
| -6% | -$125K | 0.17% | 101 |
|
|
2018
Q3 | $2.33M | Sell |
37,481
-1,098
| -3% | -$65.2K | 0.18% | 96 |
|
|
2018
Q2 | $2.13M | Sell |
38,579
-153,579
| -80% | -$8.29M | 0.18% | 98 |
|
|
2018
Q1 | $12.2M | Sell |
192,158
-9,352
| -5% | -$602K | 1.02% | 31 |
|
|
2017
Q4 | $12.3M | Buy |
201,510
+46,172
| +30% | +$2.89M | 1% | 34 |
|
|
2017
Q3 | $9.9M | Sell |
155,338
-4,602
| -3% | -$269K | 0.84% | 43 |
|
|
2017
Q2 | $8.91M | Sell |
159,940
-1,063
| -0.7% | -$57.8K | 0.79% | 45 |
|
|
2017
Q1 | $8.76M | Buy |
161,003
+48,918
| +44% | +$2.68M | 0.78% | 46 |
|
|
2016
Q4 | $6.55M | Buy |
112,085
+68,195
| +155% | +$3.73M | 0.63% | 67 |
|
|
2016
Q3 | $2.37M | Sell |
43,890
-1,849
| -4% | -$119K | 0.22% | 92 |
|
|
2016
Q2 | $3.36M | Sell |
45,739
-2,017
| -4% | -$143K | 0.32% | 83 |
|
|
2016
Q1 | $3.05M | Sell |
47,756
-860
| -2% | -$54.2K | 0.29% | 84 |
|
|
2015
Q4 | $3.46M | Buy |
+48,616
| New | +$3.21M | 0.33% | 80 |
|
Other funds holding BMY
VCM
VPM
Citizens Financial Group's BMY Position: Q1 2026 in Review
Citizens Financial Group increased its Bristol-Myers Squibb (BMY) stake by 54% in Q1 2026, buying an estimated $1.64M and bringing the position to 80,552 shares worth $4.89M. The position accounts for 0.07% of the portfolio, ranked #185.
Citizens Financial Group first reported a position in BMY in Q4 2015 and has held it in 42 quarters since. The position peaked at $12.3M in Q4 2017. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Citizens Financial Group held 80,552 shares of Bristol-Myers Squibb worth $4.89M as of Q1 2026.
- Citizens Financial Group bought 28,098 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.64M.
- Bristol-Myers Squibb made up 0.07% of Citizens Financial Group's portfolio in Q1 2026, its #185 holding.
- Citizens Financial Group first reported a position in Bristol-Myers Squibb in Q4 2015 and has held it in 42 quarters since.
- Citizens Financial Group's Bristol-Myers Squibb position peaked at $12.3M in Q4 2017.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Citizens Financial Group's 13F filing for Q1 2026, filed 1 May 2026.